-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
Galectin Therapeutics Inc annual/quarterly Net Cash Provided by (Used in) Investing Activities history and growth rate for Q1 2014.
- Galectin Therapeutics Inc Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2014 was -$400K.
- Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Investing Activities for 2023 was $0.000.
- Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Investing Activities for 2022 was $0.000.
- Galectin Therapeutics Inc annual Net Cash Provided by (Used in) Investing Activities for 2021 was $0.000.